Tumor-induced immune suppression : mechanisms and therapeutic reversal /
Saved in:
| Imprint: | New York, NY : Springer, c2008. |
|---|---|
| Description: | 1 online resource (ix, 301 p.) : ill. |
| Language: | English |
| Subject: | |
| Format: | E-Resource Book |
| URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/8884771 |
Table of Contents:
- Introduction
- Mechanisms and Therapeutic Reversal of the Defects in T-Cell Function in Cancer
- Molecular Mechanisms of Tumor-Associated T-Cell Tolerance
- T-Cell Tolerance
- T-Cell Inhibitory Molecules and Suppression of T-Cell Function In Cancer
- CTLA-4 and T-Cell Tolerance in Cancer
- Regulatory T-Cells in Cancer
- T-Cell Apoptosis in Cancer
- Defects in Dendritic Cell Differentiation in Cancer and Tumor Escape
- Dendritic Cells With Tolerogenic Potential in Cancer
- Signaling Pathways in Antigen-Presenting Cells Involved in Induction of T-Cell Tolerance
- Macrophages and Tumor Development
- Immature Myeloid Suppressor Cells in Tumor-Induced T-Cell Tolerance
- Arginin Metabolism as A Critical Element of Tumor Suppression in Cancer
- Role of Reactive Oxygen Species in T-Cell Defects in Cancer
- Cytokine Production in Cancer and their Negative Effect on Immune Response
- Inflammation and Immune Abnormalities in Cancer
- Tumor Stroma and Antitumor Immune Response
- Tumor Associated Immune Defects. Where are Now and Where are We Going